The Portugal Tax Authority has finally closed a longstanding dispute that stripped cancer survivors of income tax relief after routine medical reassessments, following an April directive that permits thousands of affected taxpayers to retroactively reclaim overpaid amounts—though not automatically.
The resolution centers on a technical but financially consequential battle: under Portuguese law, residents with a certified disability rating above 60% qualify for reduced IRS (personal income tax) obligations. Since 2021, statutes have stipulated that if a person's disability rating drops below that threshold upon reassessment, they should retain whichever tax treatment is more favorable. Yet for years, the Autoridade Tributária e Aduaneira (AT) interpreted the rule narrowly, revoking relief after a single downward reassessment—a stance that generated hundreds of disputes and five decisive rulings from the Supreme Administrative Court in favor of taxpayers.
Why This Matters
• Backdated refunds available: Cancer patients and others who lost tax relief between 2021 and 2024 can now file substitute declarations within two years or lodge formal appeals within four years.
• Manual opt‑in required: The AT lacks access to national health records, meaning no automatic correction—affected residents must initiate claims themselves via the Portal das Finanças (Portugal's online tax portal).
• Sliding-scale relief after 2024: If your reassessment occurred on or after January 1, 2024, and your rating falls between 20% and 59%, you qualify for a four‑year phase‑out worth 1.5× the Social Support Index (IAS)—Portugal's annually-adjusted benchmark for social benefits—approximately €103 in 2026 as a fixed deduction from your final tax bill, rather than reduced tax brackets applied to all income.
How the Supreme Court Shifted the Playing Field
Between late 2025 and early 2026, Portugal's highest administrative bench issued five concordant judgments clarifying that the "most‑favorable assessment" principle protects taxpayers until a second consecutive medical evaluation confirms disability below 60%. The tribunal's reasoning rests on the phrase embedded in the 2021 amendment: the protection lapses only "when both assessments under consideration reflect a disability grade below 60%."
That legal anchor upended the AT's previous practice, which treated the first drop as dispositive. In testimony before the Parliamentary Committee on Budget, Finance, and Public Administration (COFAP), State Secretary for Tax Affairs Cláudia Reis Duarte declared the matter "resolved today," noting that the agency published Circular Notice 20292 in April to align internal guidelines with the stabilized jurisprudence.
Who Wins—and How to Collect
The directive creates two timelines, hinging on whether your first post‑diagnosis reassessment took place before or after December 31, 2023.
Evaluated through 2023
If your initial medical review occurred by December 31, 2023, and your certified disability fell short of 60%, you retain the prior reduced‑rate treatment indefinitely until a second consecutive evaluation by the junta médica (the medical review board that conducts disability assessments) also registers sub‑60%. Should that second review occur in 2026, you continue to enjoy reduced IRS for this year; only after two back‑to‑back sub‑threshold ratings does the benefit vanish.
To recover overpaid tax from prior years:
Substitute declaration: File a corrected Model 3 return within two years of the original filing deadline.
Formal appeal (reclamação graciosa): Request reversal within two years, citing the Supreme Court line.
Revision for administrative error: Seek review up to four years post‑liquidation, or at any time if the liability remains unpaid, grounding the claim in "error attributable to the services."
Evaluated from 2024 onward
If your first reassessment happened on or after January 1, 2024, you keep the reduced rate for that calendar year. Thereafter, the outcome depends on your certified rating:
• 20% to 59%: A four‑year transitional schedule kicks in, offering annual deductions to the final tax due rather than the former reduced tax brackets on all income. For 2026, the value sits at 1.5 IAS (approximately €103, given the current IAS of €509.26).
• Below 20%: No relief at all.
This two‑tier mechanism reflects the State Budget for 2024 (Law 82/2023), which introduced the phase‑out regime to balance Treasury concerns with ongoing recognition of residual impairment.
Why the Process Remains Manual
Reis Duarte told lawmakers that the AT "does not yet have information sources" to apply corrections automatically because medical records—including the Atestado Médico de Incapacidade Multiuso (AMIM)—remain within the National Health Service and are not systematically shared with tax databases. While Portugal is advancing a unified electronic health record by mid‑2025 and participates in the European Health Data Space, health‑to‑tax interoperability still requires explicit taxpayer consent under the General Data Protection Regulation (GDPR).
In practice, that means cancer survivors must proactively register their AMIM on the Portal das Finanças e‑desk and separately file corrective returns or appeals to trigger refunds. The government estimates the dispute affected "thousands" of individuals, though no official tally has been published.
Political Reactions: Justice or Populism?
JPP Deputy Filipe Sousa, who requested Reis Duarte's COFAP appearance, accused the AT of prioritizing revenue "to the detriment of social justice," noting that oncological patients endure lasting physical and social sequelae even when statistical disability ratings improve. He framed the controversy as emblematic of bureaucratic inflexibility.
Reis Duarte rejected any accusation of intent to harm. "The human dimension is not at issue here," she insisted, attributing the confusion to a legitimate interpretive grey area that courts eventually clarified.
CDS‑PP Deputy Paulo Núncio went further, dismissing the critique as "pure populism," arguing that characterizing the AT as persecuting cancer patients ignores the complex statutory language and the agency's ultimate responsiveness to Supreme Court precedent.
Medical‑Evaluation Backdrop
Under Portugal's National Disability Table (TNI), physicians assess impairment by weighing tumor location and spread, treatment sequelae—surgical disfigurement, chemotherapy toxicity, radiation damage—functional deficits, and recurrence risk. Recent diagnoses automatically confer a minimum 60% rating for five years (Law 1/2024), sparing newly diagnosed patients from immediate medical review board assessments. Once that initial window expires, reassessments become individualized, and percentage thresholds can fluctuate based on clinical evolution.
That variability is what drove the original AT policy: officials reasoned that a patient whose impairment declined no longer met the legislative threshold. The Supreme Court disagreed, reading the 2021 safeguard as a deliberate buffer against single‑assessment volatility.
How Much Money Is at Stake?
The refund depends on your income and disability rating. For example, a taxpayer earning €30,000/year who qualified for reduced rates but was incorrectly taxed at standard rates for three years could reclaim €1,500–€3,000. The AT has not published aggregate figures, but consumer advocates estimate thousands of residents are affected.
Most residents will need to file their claim through the Portal das Finanças, either submitting a corrected Model 3 tax return online or formally appealing through the platform. If you hold a Non-Habitual Resident (NHR) status, the same rules apply to your Portuguese-source income; consult a fiscal representative if your situation involves cross-border tax implications. A fiscal representative (representante fiscal) is recommended for complex appeals, though not legally required for substitute declarations filed electronically.
What Residents Should Do Now
Locate your AMIM certificate and verify the date of each medical evaluation from the National Health Service.
Cross‑check your IRS liquidations for 2021, 2022, 2023, and 2024 via Portal das Finanças. Look for any year in which reduced‑rate brackets or exclusions were disallowed. You can access this through your account dashboard under "Deduções" and "Retenções."
File a substitute Model 3 or appeal within the applicable deadline—two years from the original filing date for substitutes, four years from liquidation for administrative‑error reviews. Submissions are made via Portal das Finanças under "Declarações" or through a fiscal representative.
Document your timeline: If you underwent reassessments in consecutive years, map them against the two‑evaluation rule to confirm eligibility.
Legal observers note that while Circular 20292 resolves the interpretive standoff, its manual opt‑in design may leave less‑connected taxpayers unaware of their entitlement. Consumer‑rights groups are calling for a targeted information campaign and, eventually, automated cross‑referencing once digital‑health infrastructure permits compliant data flows.
For now, affected residents must initiate claims themselves—patient advocacy groups recommend acting quickly to preserve deadlines.
